Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
03/2008
03/20/2008WO2007115829A3 Anti ku70 internalizing antibodies
03/20/2008WO2007113648A3 Ctla4 antibody combination therapy
03/20/2008WO2007109290A3 Water-soluble zinc ionophores, zinc chelators, and/or zinc complexes and use for treating cancer
03/20/2008WO2007106617A3 Method of treatment and prophylaxis of diseases related to amyloid deposition using igm
03/20/2008WO2007106404A3 Vaccine for viruses that cause persistent or latent infections
03/20/2008WO2007106224B1 Method of detecting or diagnosing of a neurodegenerative disease or condition
03/20/2008WO2007092861A3 Inhibitors specific of presenilin-1 and their uses
03/20/2008WO2007075335A3 Modulation of in utero immune programming
03/20/2008WO2007047938A3 Influenza viruses able to infect canids, uses thereof
03/20/2008WO2004111075A3 Alternative reading frame polypeptides for treatment
03/20/2008WO2001025398A3 Process for inducing functional tolerance to gene transfer products
03/20/2008US20080071069 For delivering DNA/RNA into cells
03/20/2008US20080070855 Preventing post-operative neovascularization in ophthalmic tissue; administering bevacizumab
03/20/2008US20080070831 Endothelial growth factor; isolated polypeptide; stimulates cell proliferation, neovascularization, vascular system permeability; uses thereof in medical and diagnostic applications
03/20/2008US20080070799 Binding molecules capable of neutralizing rabies virus and uses thereof
03/20/2008US20080070265 Using immunoglobulins specific to apolipoproteins as diagnostic tool in detection of cardiovascular disorders
03/20/2008US20080069867 Diagnostic and/or Remedy for Ovarian Cancer
03/20/2008US20080069866 Immunotherapeutic methods and compositions
03/20/2008US20080069853 Sustained release of antibodies in milk; insertion of antigen releasing device in mammary glands lymph nodes
03/20/2008US20080069844 Mucosal Vaccine Adjuvants Containing Bacterial Flagellins as an Active Component
03/20/2008US20080069843 Prevention of microbial pathogenesis; administering mixture of mutant Salmonella bacteria and carrier
03/20/2008US20080069842 Vaccines for Mycoplasma bovis and methods of use
03/20/2008US20080069841 Pharmaceutical Compositions Containing Botulinum Neurotoxin A2
03/20/2008US20080069840 Immunotherapy ; antigen codes Dna vaccine; antitumor agents
03/20/2008US20080069839 Isolation and characterization of the precursor virus of human sars virus: sars-associated corona virus-like virus
03/20/2008US20080069838 Novel human virus causing severe acute respiratory syndrome (sars) and uses thereof
03/20/2008US20080069837 Composition and method for treating cancer using herpes virus
03/20/2008US20080069836 Method of using adenoviral vectors with increased immunogenicity in vivo
03/20/2008US20080069835 Diphtheria, tetanus, diphtheria, deactivated polio virus, hepatitis B surface antigen in container with protein carrier
03/20/2008US20080069833 Anticancer agents; mixture of fusion protein and yeast vehicle
03/20/2008US20080069832 Shiga-like toxin which binds to receptor; complexing with antigen
03/20/2008US20080069831 Vaccines; fusion protein; induce immunology response
03/20/2008US20080069830 Isolation Dna; nucleotide sequences; genetic engineering
03/20/2008US20080069829 Ability to bind to antibodies; diagnosis of allergies
03/20/2008US20080069828 Detection of glandular disorders; bone disease ; calibrate different peptide fragments from whole parathyroid hormone; binding to antibody
03/20/2008US20080069827 miRNA of HSV-LAT and uses thereof
03/20/2008US20080069826 Novel Genes Associated with the Maintenance of Differentiation of Smooth Muscle Cells
03/20/2008US20080069825 Multiple CpG oligodeoxynucleotides and their use to induce an immune response
03/20/2008US20080069824 Size-variable strain-specific protective antigen for Potomac horse fever
03/20/2008US20080069823 Attenuation of Reperfusion Injury
03/20/2008US20080069822 Immunoglobulins; cell line; screening; side effect reduction
03/20/2008US20080069821 Avian pandemic; immunogens; antibodies; immunology
03/20/2008US20080069820 Mutations within light chain variable domain; antitumor agents
03/20/2008US20080069819 Method and composition for detecting cancer by means of detection of epstein-barr virus nuclear antigen 2 coactivator p100
03/20/2008US20080069818 Method of Increasing Efficacy of Tumor Cell Killing Using Combinations of Anti-Neoplastic Agents
03/20/2008US20080069817 Heteroaryl-fused pyrimidinyl compounds as anticancer agents
03/20/2008US20080069816 Carcinoembryonic antigen (CEA); utilizes crystallographic structural data to select immunoglobulin framework having maximum structural overlap non-human donor molecule
03/20/2008US20080069815 Autoimmune diseases; rheumatic arthritis
03/20/2008US20080069814 High dosage administered without inducing severe symptomatic hypercalcemia
03/20/2008US20080069813 Acid hydrolyzed IgG concentrate which prevents viral invasion
03/20/2008US20080069812 Inhibitors of apoptosis proteins (IAP); antiproliferative agents; anticancer agents
03/20/2008US20080069811 Follicle stimulating hormone (Fsh); bioavailability; drug screening
03/20/2008US20080069795 Depleting T cells in the patient prior to a administration of a platinum-containing compound
03/20/2008US20080069777 Conformation Specific Antibodies
03/20/2008US20080069775 Administering anti-idiotype antibody or antibody fragment comprising heavy chain variable region sequences and light chain variable region sequences conjugated to a soluble immunogenic carrier protein
03/20/2008US20080069772 Treatment of transformed or infected biological cells
03/20/2008US20080069770 Monoclonal antibodies; used to modulate the immune system; no modulation of the totality of the T-cell population but only of the sub-assembly of T-cells expressing the beta sub-family specific to the T-cell receptors; used for organ transplant rejection
03/20/2008CA2664333A1 Methods of diagnosing, treating, or preventing plasma cell disorders
03/20/2008CA2664327A1 Method for detecting and treating skin disorders
03/20/2008CA2663701A1 Vaccine
03/20/2008CA2663577A1 Kinase inhibitors useful for the treatment of proliferative diseases
03/20/2008CA2663295A1 Alphavirus replicon particles matched to protein antigens as immunological adjuvants
03/20/2008CA2663196A1 Making influenza virus vaccines without using eggs
03/20/2008CA2663166A1 Heat treated bacterins, and emulsion vaccines prepared from such heat treated bacterins
03/20/2008CA2662962A1 Polyalkylene oxides having hindered ester-based biodegradable linkers
03/20/2008CA2662549A1 Il-1 family variants
03/20/2008CA2662531A1 Treatment of multiple sclerosis (ms) with campath-1h
03/19/2008EP1901071A1 Methods of diagnosing, preventing and treating infection with hepatitis c virus
03/19/2008EP1900827A2 Methods and compositions for the prediction, diagnosis, prognosis, prevention and treatment of malignant neoplasia
03/19/2008EP1900818A2 Neisserial antigens
03/19/2008EP1900816A2 GL50 molecules and uses therefor
03/19/2008EP1900814A1 sc(Fv)2 SITE-DIRECTED MUTANT
03/19/2008EP1900753A2 Method of administering therapeutic polypeptides, and polypeptides therefor
03/19/2008EP1900377A1 Inhibitors of GPR87 for cancer therapy
03/19/2008EP1900376A2 Synergistic inhibition of HIV-1 fusion and attachment, compsitions and antobodies thereto
03/19/2008EP1900375A1 Calreticulin for its use as a medication for the treatment of cancer in a mammal
03/19/2008EP1899487A2 Gfats as modifiers of the axin pathway and methods of use
03/19/2008EP1899477A2 An integrated approach for generating multidomain protein therapeutics
03/19/2008EP1899470A2 System for rapid production of high-titer and replication-competent adenovirus-free recombinant adenovirus vectors
03/19/2008EP1899462A1 Stable aqueous systems comprising proteins
03/19/2008EP1899459A2 Obtention of food- or auto-antigen specific tr1 cells from a leukocyte or pbmc population
03/19/2008EP1899380A1 Idiotype vaccination with bispecific and multispecific immunoglobulin molecules
03/19/2008EP1899378A2 Il-1 beta binding antibodies and fragments thereof
03/19/2008EP1899377A2 Humanised antibodies specific for nogo-a and phrarmaceutical uses thereof
03/19/2008EP1899376A2 Antibodies against hmgb1 and fragments thereof
03/19/2008EP1899371A2 Method for preparing a covalently cross linked oligomer of amyloid beta peptides
03/19/2008EP1899367A1 Mutant allergen(s)
03/19/2008EP1899363A1 Method for identifying modulators of rufy2 useful for treating alzheimer's disease
03/19/2008EP1898957A1 Chemotherapeutic formulations of zosuquidar trihydrochloride and modified cyclodextrins
03/19/2008EP1898950A2 Galk1s as modifiers of the pten/akt pathway and methods of use
03/19/2008EP1898949A1 Vaccination by transcutaneous targeting
03/19/2008EP1898948A1 Polyinosinic acid-polycytidylic acid-based adjuvant
03/19/2008EP1898947A2 Botulinum toxin and the treatment of primary disorders of mood and affect
03/19/2008EP1898946A1 Treatment of patients with cancer using a calicheamicin-antibody conjugate in combination with zosuquidar
03/19/2008EP1898916A2 Zosuquidar, daunorubicin, and cytarabine for the treatment of cancer
03/19/2008EP1898701A1 Delivery of active proteins to the central nervous system using phage vectors
03/19/2008EP1711174B1 Adjuvant compositions
03/19/2008EP1590435B1 Depletion of endogenous primordial germ cels in avian species
03/19/2008EP1428880B1 Kidney-specific urate transporter and gene thereof
03/19/2008EP1383556B9 INJECTION DEVICE FOR ADMINISTERING mRNA
1 ... 774 775 776 777 778 779 780 781 782 783 784 785 786 787 788 789 790 791 792 793 794 ... 1823